Wirecard: how to find a €2bn hole
The Story of Money14 Juli 2020

Wirecard: how to find a €2bn hole

In September 2014, the FT’s Dan McCrum received a tip about a fast-growing German fintech group, Wirecard. Over the next couple of years Dan and his colleagues uncovered the secret behind the payment company’s meteoric growth: many of the customers listed in company documents did not exist. In this episode Dan tells the story of the whistleblowers, shoe-leather reporting, hacking, suspected surveillance and legal threats that led to Wirecard’s downfall.


---

Review clips: CNBC, Deutsche Welle


Further reading:


The double life of Wirecard’s Jan Marsalek https://www.ft.com/content/511ecf86-ab40-486c-8f76-b8ebda4cc669


Inside Wirecard

https://www.ft.com/wirecard


Dan’s 2015 story for Alphaville

https://ftalphaville.ft.com/2015/04/27/2127427/the-house-of-wirecard/

Hosted on Acast. See acast.com/privacy for more information.

Avsnitt(319)

KKR, Bain and private equity’s push into Japan

KKR, Bain and private equity’s push into Japan

When international private equity groups first entered Japan at the turn of the 21st century, newspapers criticised them as vulture funds and politicians steered clear of public contact. Today, it’s a...

26 Nov 202521min

Coming soon from Tech Tonic: Defying death

Coming soon from Tech Tonic: Defying death

Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing...

24 Nov 20251min

What’s the deal with OpenAI's deals?

What’s the deal with OpenAI's deals?

OpenAI is entering a new era. It's restructured to add a for-profit arm to its business and has signed more than a trillion dollars’ worth of deals to secure chips and build out data centres. But thos...

19 Nov 202526min

Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multib...

12 Nov 202526min

The $17bn nuclear start-up without any revenue

The $17bn nuclear start-up without any revenue

Publicly-listed Oklo sits at the intersection of two hot areas for Wall Street: artificial intelligence and energy companies. This year alone, Oklo’s share price has jumped more than 400 per cent. But...

5 Nov 202523min

$12bn of debt: How First Brands Group collapsed

$12bn of debt: How First Brands Group collapsed

Some of the world’s biggest financial institutions are reeling after the collapse of a little-known car parts supplier: First Brands Group. The company filed for bankruptcy last month, and since then,...

29 Okt 202526min

Can the world’s largest listed hedge fund rebound?

Can the world’s largest listed hedge fund rebound?

The world’s largest listed hedge fund manager, Man Group, is at a crossroads. After years of high flying thanks to its innovative quant trading strategies, the company’s hedge fund unit has been falte...

22 Okt 202519min

Introducing Untold: Toxic Legacy

Introducing Untold: Toxic Legacy

Introducing Toxic Legacy, a new season of Untold from the Financial Times. Host Laura Hughes uncovers a lead poisoning epidemic across the UK. You might be living with lead and not know it: the toxin ...

16 Okt 20252min

Populärt inom Business & ekonomi

framgangspodden
badfluence
varvet
rss-jossan-nina
svd-tech-brief
rss-svart-marknad
rss-borsens-finest
uppgang-och-fall
avanzapodden
bathina-en-podcast
lastbilspodden
rss-dagen-med-di
fill-or-kill
rss-inga-dumma-fragor-om-pengar
rss-kort-lang-analyspodden-fran-di
24fragor
borsmorgon
tabberaset
rikatillsammans-om-privatekonomi-rikedom-i-livet
montrosepodden